Relationship Between Natural Killer Cells’ Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2

Sponsors and Collaborators
Cancer and Leukemia Group B


Continue Reading

National Cancer Institute (NCI)

Contact
ClinicalTrials.gov identifier: NCT00896701
 
Principal Investigators
Sherif S. Farag, MD, PhD
Indiana University Melvin and Bren Simon Cancer Center
 
ClinicalTrials.gov Identifier
NCT00896701